Skip to main content
. 2018 Dec 21;3(12):17991–18001. doi: 10.1021/acsomega.8b02840

Table 1. Cytotoxic Data of Compound 20 against NCI-60 Cell Lines.

    20
cancer panel cell line GI50 TGI LC50
leukemia HL-60(TB) 2.00 5.35 >10
K-562 1.82 9.08 >10
MOLT-4 1.69 7.89 >10
RPMI-8226 1.91 5.65 >10
NSCLC HOP-92 2.44 5.63 >10
NCI-H226 1.94 4.39 >10
NCI-H460 2.79 8.27 >10
NCI-H522 2.40 6.35 >10
colon cancer COLO 205 2.42 5.46 >10
HCT-116 1.73 3.56 7.33
HCT-15 1.56 4.17 >10
SW-620 2.14 4.50 >10
CNS cancer SF-295 1.59 4.91 >10
SF-539 1.04 2.48 5.90
melanoma LOX IMVI 1.74 3.36 6.47
MALME-3M 1.80 4.13 9.48
SK-MEL-28 1.53 4.07 >10
UACC-62 1.90 5.70 >10
ovarian cancer IGROV1 2.09 4.88 >10
OVCAR-3 1.92 3.79 7.47
SKOV-3 2.91 9.13 >10
renal cancer 786-0 1.30 2.80 >10
ACHN 1.64 3.01 5.53
CAKI-1 1.87 3.76 7.57
RXF 393 1.41 2.94 6.14
TK-10 2.77 8.29 >10
UO-31 1.61 2.98 5.54
prostate cancer DU-145 2.01 4.13 >10
breast cancer MCF7 1.78 4.26 >10
MDA-MB-231/ATCC 2.60 7.34 >10
BT-549 2.20 8.06 >10
T-47D 2.00 5.24 >10
MDA-MB-468 1.95 4.27 >10